THTX — Theratechnologies Balance Sheet
0.000.00%
HealthcareAdventurousSmall CapNeutral
- $94.09m
- $130.92m
- $80.06m
- 42
- 46
- 25
- 30
Annual balance sheet for Theratechnologies, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
R2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 48.7 | 40.6 | 20.8 | 40.4 | 33.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11 | 10.1 | 13.2 | 10.9 | 12.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 73.6 | 76.2 | 64.8 | 91.9 | 73.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.101 | 1.07 | 3.48 | 2.85 | 3.09 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 111 | 118 | 100 | 119 | 93.3 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 26.9 | 37.1 | 41.9 | 45.1 | 114 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 76.1 | 92.7 | 96.9 | 101 | 116 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 35 | 24.8 | 3.22 | 17.8 | -22.6 |
Total Liabilities & Shareholders' Equity | 111 | 118 | 100 | 119 | 93.3 |
Total Common Shares Outstanding |